<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Allergy Rhinol (Providence)</journal-id><journal-id journal-id-type="iso-abbrev">Allergy Rhinol (Providence)</journal-id><journal-id journal-id-type="pmc">ar</journal-id><journal-title-group><journal-title>Allergy &#x00026; Rhinology</journal-title></journal-title-group><issn pub-type="ppub">2152-6575</issn><issn pub-type="epub">2152-6567</issn><publisher><publisher-name>OceanSide Publications, Inc.</publisher-name><publisher-loc>Providence, RIUSA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25860169</article-id><article-id pub-id-type="pmc">4388875</article-id><article-id pub-id-type="publisher-id">AR023-14</article-id><article-id pub-id-type="doi">10.2500/ar.2015.6.0108</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>A retrospective study of peanut and tree nut allergy: Sensitization and correlations with clinical manifestations</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Lihua</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Clements</surname><given-names>Stacy</given-names></name><degrees>B.S.</degrees><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Joks</surname><given-names>Rauno</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="aff1"/></contrib><aff id="aff1">From the Department of Internal Medicine, State University of New York Downstate Medical Center, Center for Allergy and Immunology, Brooklyn, New York</aff></contrib-group><author-notes><corresp>Address correspondence to Rauno Joks, M.D., State University of New York Downstate Medical Center, 450 Clarkson Avenue, Box 50, Brooklyn, NY 11203 E-mail address: <email>Rauno.Joks@downstate.edu</email></corresp></author-notes><pub-date pub-type="ppub"><season>Spring</season><year>2015</year></pub-date><volume>6</volume><issue>1</issue><fpage>e39</fpage><lpage>e43</lpage><permissions><copyright-statement>Copyright &#x000a9; 2015, OceanSide Publications, Inc., U.S.A.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access"><license-p>This publication is provided under the terms of the Creative Commons Public License ("CCPL" or "License"), in attribution 3.0 unported (Attribution Non-Commercial No Derivatives (CC BY-NC-ND)), further described at: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode">http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode</ext-link>. The work is protected by copyright and/or other applicable law. Any use of the work other then as authorized under this license or copyright law is prohibited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="arhe39.pdf"/><abstract><p>Peanut (PN) and tree nut (TN) allergies are among the leading causes of fatal food-induced anaphylaxis and are increasing in prevalence, especially in children. Their cosensitization and concurrent clinical allergy have been understudied. This retrospective study investigated the correlation between PN and TN allergy, both in terms of in vitro sensitization (IVS) and clinical allergic manifestations. We conducted a retrospective medical record review at the Allergy Clinic at University Hospital of Brooklyn. Fourteen hundred six charts were reviewed, of which 76 (5.4%) had documented relevant clinical allergy: PN allergy but not TN allergy (n = 29) or TN allergy but not PN allergy (n = 11) or both (n = 30). Six patients with PN allergy but no TN exposure history were not included in the analysis. The majority of patients (67/76, 88.1%) had a concurrent history of asthma, rhinoconjunctivitis, or AD. Sensitivity of TN IVS predicting PN IVS was 38/39 (97%). Similarly, sensitivity of PN IVS predicting TN IVS was 38/42 (91%). Sensitivity of TN clinical allergy predicting PN allergy was 30/59 (51%). Sensitivity of PN clinical allergy predicting TN allergy was 30/41 (73%). The total number of organ systems involved in reported clinical reactions correlated with IVS to TN (p = 0.004) but not IVS to PN (p = 0.983). In summary, we found PN sensitization predicts TN sensitization <italic>in vitro</italic>, with lower predictability for clinical reactions.</p></abstract><kwd-group><kwd>Allergy</kwd><kwd>clinical reaction</kwd><kwd>cosensitization</kwd><kwd>cross-reactivity</kwd><kwd>peanut</kwd><kwd>sensitization</kwd><kwd>tree nut</kwd></kwd-group></article-meta></front><body><p>Peanut (PN) and tree nut (TN) allergies can be severe and account for a relatively high proportion of fatal food-induced anaphylaxis.<sup><xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref></sup> These allergies can be lifelong<sup><xref rid="B3" ref-type="bibr">3</xref></sup> and appear to be increasing in prevalence, especially in children.<sup><xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref></sup> The current prevalence of nut allergy (2%) has doubled in the past 10 years.<sup><xref rid="B5" ref-type="bibr">5</xref></sup> PN and TN allergy are a major health concern.<sup><xref rid="B6" ref-type="bibr">6</xref></sup> PN is a legume, the same family as beans such as soy and peas,<sup><xref rid="B7" ref-type="bibr">7</xref></sup> and is different from TNs. Studies have shown cross-reactive allergen epitopes between PNs and TNs<sup><xref rid="B8" ref-type="bibr">8</xref>,<xref rid="B9" ref-type="bibr">9</xref></sup> but whether this results in clinical cross-reactivity remains unclear. This cohort study investigated the correlation between PN and TN allergy, in terms of clinical allergic manifestations and <italic>in vitro</italic> sensitization (IVS).</p><sec sec-type="methods"><title>METHODS</title><p>We conducted a retrospective medical chart review (2003&#x02013;2012) at the Allergy Clinic at University Hospital of Brooklyn. Cases of children (&#x0003e;3 years old) and adults who had PN and/or TN allergy (include cashew, walnut, almond, hazelnut, pistachio, or pecan) were reviewed. Presence of concurrent allergic disease including allergic rhinoconjunctivitis, asthma, and atopic dermatitis (AD) was also included in the database. This study was approved by the Institutional Review Board from State University of New York Downstate Medical Center. The data were collected without identifiers, and all of the information was kept confidential.</p><p>The total number of organ systems involved in clinical reactivity was determined, including dermatologic (urticaria, pruritus, angioedema, swelling, and worsening of AD), respiratory (wheezing, throat tightness, shortness of breath, cough, and tight chest), gastrointestinal (nausea, vomiting, diarrhea, and abdominal pain), and neurological (dizziness and syncope). Degree of IVS was quantified as follows: 0, not reactive (IgE, &#x0003c;0.35 kU/L); 1, weakly reactive (IgE, 0.35&#x02013;0.7 kU/L); 2, moderately reactive (IgE, 0.7&#x02013;3.5 kU/L); 3, highly reactive (HR; IgE, 3.5&#x02013;17.5 kU/L); 4, very highly reactive (VHR; IgE, 17.6&#x02013;100kU/L; Quest Diagnostics, Madison, NJ). For patients with multiple TN sensitivities by serum IgE, the greatest level of sensitivity was used in statistical analysis. Spearman correlation coefficients were generated to determine the relationship between total allergic reaction organ involvement and level of <italic>IVS</italic>.</p><p>Statistical data analysis was performed using SAS Version 9.3 software (SAS, Cary, NC).</p></sec><sec sec-type="results"><title>RESULTS</title><p>Of 1406 charts were reviewed; 76 (5.4% of 1406) patients were identified with self-reported PN or TN allergy.</p><sec><title>Demographic Profile</title><p>As shown in <xref ref-type="table" rid="T1">Table 1</xref>, the majority of this population was African&#x02013;American (89.4%) and had concurrent allergic disease (88.1%) including allergic rhinoconjunctivitis (57.9%), asthma (25%), and AD (22.3%).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Demographic profile of PN- and/or TN-allergic subjects (<italic>n</italic> = 76)</p></caption><graphic xlink:href="arh00115-0108-t01"/><table-wrap-foot><fn fn-type="other"><p>AD = atopic dermatitis; PN = peanut; TN = tree nut.</p></fn></table-wrap-foot></table-wrap><p>Of the 76 identified subjects with PN or TN allergy, 8 (10.5%) had no associated second allergic disease. Of these 8 subjects, 6 had PN allergy only, 1 had both PN allergy and hazelnut allergy, and 1 had TN allergy only.</p></sec><sec><title>The Most Common Clinical Reaction Was Angioedema</title><p>As shown in <xref ref-type="table" rid="T2">Table 2</xref>, angioedema involving lip, tongue, throat, eye, or whole face was reported as the most common reaction in both PN allergy (55.9%) and TN allergy (46.3%) patients, followed by skin manifestations including urticaria and pruritus in PN (52.5%) and TN (41.4%) allergic patients. Respiratory issues including wheezing, dyspnea, and laryngeal edema were reported in 25.4% of PN allergic patients and in 17% of TN allergy patients. There were no reports of hypotensive symptoms including dizziness or syncope. Anaphylaxis (involving two or more than two systems)<sup><xref rid="B10" ref-type="bibr">10</xref></sup> was reported in 23.7% of PN allergy patients and in 21.9% of TN allergy patients.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Clinical reactions to PN and TN</p></caption><graphic xlink:href="arh00115-0108-t02"/><table-wrap-foot><fn fn-type="other"><p>PN = peanut; TN = tree nut.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>One-Half of Patients with Clinical PN Allergy Had Clinical Allergy to TN</title><p>Of those reporting allergic reactions, 38.1% (29/76) of patients reported PN allergy only, 14.5% (11/76) of patients reported TN allergy only, and 39.5% (30/76) of patients reported both PN and TN allergies. In total, 59/76 (77.6%) patients reported PN allergy and 41/76 (53.9%) patients reported TN allergy.</p><p>Of all patients with PN allergy, 30/59 (51%) had documented clinical allergy to TN. Sensitivity of TN clinical allergy predicting PN allergy was 30/59 (51%). Sensitivity of PN clinical allergy predicting TN allergy was 30/41 (73%), (<xref ref-type="table" rid="T3">Table 3</xref>). Patients with no exposure history or unknown reactions to TN were considered frequency missing and were not included in data analysis.</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Frequency of concurrence of PN and TN reported clinical allergy</p></caption><graphic xlink:href="arh00115-0108-t03"/><table-wrap-foot><fn fn-type="other"><p>Self-reported clinical allergy reaction to PNs and TNs. Reviewed 1330 cases that can not be characterized&#x02014;no reaction or do not know.</p></fn><fn fn-type="other"><p>Frequency missing = 6.</p></fn><fn fn-type="other"><p>PN = peanut; TN = tree nut.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>IVS to PN and TN</title><p>The distribution of IVS to PN and TN is shown in <xref ref-type="table" rid="T4">Table 4</xref>. Sensitivity of TN IVS predicting PN IVS was 38/39 (97%). Similarly, sensitivity of PN IVS predicting TN IVS was 38/42 (91%; <xref ref-type="table" rid="T4">Table 4</xref>). There was a significant correlation between PN IVS and each type of TN sensitization: hazelnut, <italic>p</italic> &#x0003c; 0.001; cashew, <italic>p</italic> = 0.001; walnut, <italic>p</italic> &#x0003c; 0.001; pecan. <italic>p</italic> &#x0003c; 0.001; pistachio, <italic>p</italic> &#x0003c; 0.001; and almond, <italic>p</italic> = 0.003.</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Frequency of concurrence of positive IVS (IgE) to PNs and TNs of patients reporting PN and/or TN allergy (<italic>n</italic> = 76)</p></caption><graphic xlink:href="arh00115-0108-t04"/><table-wrap-foot><fn fn-type="other"><p>Frequency missing = 21. Reviewed 1330 cases that can not be characterize&#x02014;no reaction or do not know.</p></fn><fn fn-type="other"><p>IVS = <italic>in vitro</italic> (sensitization IgE of TNs or PNs, &#x0003e;0.35 kU/L); PN = peanut; TN = tree nut.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>High PN or TN <italic>In Vitro</italic> Value Was Not Predictive of TN or PN Clinical Reactivity, Respectively</title><p>As shown in <xref ref-type="table" rid="T5">Table 5</xref>, we created a model of PN-specific IgE level of VHR (IgE, 17.6&#x02013;100 kU/L) to predict TN clinical reaction, but the relation was not statistically significant (<italic>p</italic> = 0.50). TN-specific IgE level of VHR (IgE, 17.6&#x02013;100 kU/L) predicting PN nu<bold>t</bold> clinical reaction was also not statistically significant (<italic>p</italic> = 0.21).</p><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Specific IgE level to PNs and TNs</p></caption><graphic xlink:href="arh00115-0108-t05"/><table-wrap-foot><fn fn-type="other"><p>Data include multiple sensitizations to the following nuts: hazelnut, cashew, walnut, pecan, pistachio, and almond.</p></fn><fn fn-type="other"><p>HR = highly reactive (IgE, 3.5&#x02013;17.5 kU/L); MR = moderately reactive (IgE, 0.7&#x02013;3.5 kU/L); NR = not reactive (IgE, &#x0003c;0.35 kU/L [Quest Diagnostics, Madison, NJ]); PN = peanut; TN = tree nut; VHR = very highly reactive (IgE, 17.6&#x02013;100 kU/L); WR = weakly reactive (IgE, 0.35&#x02013;0.7 kU/L).</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Total Number of Organ Systems Affected during Allergic Reactions Correlates with Serum-Specific IgE Level for TNs, But Not for PNs</title><p><xref ref-type="table" rid="T6">Table 6</xref> shows the simple statistics for the number of organ systems reported affected during allergic reactions to TN and PN as well as the level of sensitization to TN and PN. Number of affected organ systems affected in allergic reactions to TNs correlates with level of specific IgE sensitization to TNs (<italic>p</italic> = 0.0043). Number of affected organ systems affected in allergic reactions to PN does not correlate with level of specific IgE sensitization to PN (<italic>p</italic> = 0.983).</p><table-wrap id="T6" position="float"><label>Table 6</label><caption><p>Simple statistics of total number of organ systems in allergic reactions to PNs or TNs and greatest degree of IVS per subject</p></caption><graphic xlink:href="arh00115-0108-t06"/><table-wrap-foot><fn fn-type="other"><p>Each organ system symptom reported received a score of 1. Organ system symptoms included dermatologic (urticaria, pruritus, angioedema, swelling, and worsening of atopic dermatitis), respiratory (wheezing, throat tightness, shortness of breath, cough, and tight chest), gastrointestinal (nausea, vomiting, diarrhea, and abdominal pain), neurological (dizziness and syncope). Degree of IVS was quantified as follows: 0, not reactive (IgE, &#x0003c;0.35 kU/L); 1, WR (IgE, 0.35&#x02013;0.7 kU/L); 2, MR (IgE, 0.7&#x02013;3.5 kU/L); 3, HR (IgE, 3.5&#x02013;17.5 kU/L); 4, VHR (IgE, 17.6&#x02013;100 kU/L; Quest Diagnostics, Madison, NJ).</p></fn><fn fn-type="other"><p>HR = highly reactive; IVS = <italic>in vitro</italic> sensitization; MR = moderately reactive; PN = peanut; TN = tree nut; VHR = very highly reactive; WR = weakly reactive.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>This is the first study including both pediatric and adult patients to show the clinical reactivity and IVS between patients with PN and TN allergies. We found that PN sensitization highly correlates with TN sensitization <italic>in vitro</italic>. This concurrence of sensitization did not extend to clinical cross-reactivity between PN and TN. A retrospective study of TN allergy among PN-allergic children found increasing sensitization to TNs up to age 5 years.<sup><xref rid="B11" ref-type="bibr">11</xref></sup></p><p>The concurrence of IVS between PN and TNs may be caused by, in part, molecular allergen cross-reactivity between PN and TN allergens.<sup><xref rid="B8" ref-type="bibr">8</xref>,<xref rid="B9" ref-type="bibr">9</xref></sup> PN major allergens (Ara h 1, Ara h 2, and Ara h 3) are seed storage proteins as are most TN allergens.<sup><xref rid="B12" ref-type="bibr">12</xref>&#x02013;<xref rid="B15" ref-type="bibr">15</xref></sup> Seed storage proteins from PNs and TNs are considered the major allergens contributing to the anaphylactic reactions of patients with nut allergy.<sup><xref rid="B15" ref-type="bibr">15</xref></sup> PN Ara h 2 is recognized as functionally more potent and considered the most clinically important PN allergen.<sup><xref rid="B16" ref-type="bibr">16</xref>&#x02013;<xref rid="B19" ref-type="bibr">19</xref></sup> Serum IgE to Ara h 2 is an important predictor of clinical reactivity to PN. De Leon and colleagues have indicated that PN Ara h 2 shares common IgE-binding epitopes with almond and brazil nut allergens and contributes to allergenic cross-reactivity with TN proteins.<sup><xref rid="B8" ref-type="bibr">8</xref>,<xref rid="B20" ref-type="bibr">20</xref></sup> Maleki find similar IgE-binding epitopes of between walnut allergens and PN Ara h 2, contributing to cross-reactivity between nut allergen.<sup><xref rid="B21" ref-type="bibr">21</xref></sup> Whether Ara h 2 is present in almonds and contributes to their allergenicity has not been confirmed.<sup><xref rid="B22" ref-type="bibr">22</xref></sup></p><p>Barre and colleagues report PN Ara h1 allergen and TNs including walnut (Jug r 2), hazelnut (Cor a 11), and cashew nut (Ana o 1) share structurally related IgE-binding epitopes.<sup><xref rid="B9" ref-type="bibr">9</xref></sup> Sharing IgE-binding epitopes between PN (Ara h 1, Ara h 2) and TN (almond, Brazil nut, walnut, <italic>etc.</italic>) may provide an explanation that the common cosensitization or concurrent clinical reactions might be caused by the molecular cross-reaction among nuts. Whether this cosensitization or cross-reaction is associated with significant clinical reactions or with the severity of the reactions remains unknown.</p><p>Sampson reports predictability of nut clinical reaction by using food-specific IgE concentrations: PN-specific IgE concentrations of &#x02265;14 kU/L has positive predictive value of 100% of PN clinical allergy and TN-specific IgE concentrations of &#x02265;15 kU/L has positive predictive value of 95% of TN clinical allergy.<sup><xref rid="B23" ref-type="bibr">23</xref></sup> We did not find that high PN or TN <italic>in vitro</italic> value was predictive of TN or PN clinical reactivity, respectively.</p><p>Our retrospective study discovered that the extent of clinical organ system symptoms reportedly involved in food-allergic reactions to TNs correlates with serum levels of specific IgE to TNs. This correlation was not significant for allergic symptoms associated with PN allergy and serum levels of PN-specific IgE.</p><p>The limitation of the current study is that the clinical allergy diagnosis is based on self-reported allergy reaction and is not based on oral food challenge, which is the gold standard for diagnosis of food allergy.<sup><xref rid="B24" ref-type="bibr">24</xref>,<xref rid="B25" ref-type="bibr">25</xref></sup> This lack of confirmation may impair the ability of predicting the relationships between PN allergy and TN allergy. Additionally, the cohort size of patients allergic to each of the nuts is relatively small. More patients will be needed to confirm the predictability of this cosensitization or concurrent allergy between PN and the TNs.</p><p>In conclusion, PN sensitization correlates with TN sensitization <italic>in vitro</italic>, with lower sensitivity for coexistent clinical reactivity. The higher sensitivity of nut sensitization may be caused by primary cross-reactivity between PN and TN allergens as there are shared epitopes in nuts and possible cross-reactivity <italic>via</italic> different allergen components between PN and TNs, along with possible PN and TN cross-contact during the food manufacturing and processing.<sup><xref rid="B26" ref-type="bibr">26</xref></sup></p></sec></body><back><fn-group><fn fn-type="conflict"><p>The authors have no conflicts of interest to declare pertaining to this article</p></fn></fn-group><ack><title>ACKNOWLEDGMENTS</title><p>The authors acknowledge Jeremy Weedon, Ph.D., from the Scientific/Academic Computing Center at SUNY Downstate Medical Center, who provided assistance with statistical analysis.</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sampson</surname><given-names>HA</given-names></name><name><surname>Mendelson</surname><given-names>LM</given-names></name><name><surname>Rosen</surname><given-names>JP</given-names></name></person-group>
<article-title>Fatal and near-fatal anaphylactic reactions to food in children and adolescents</article-title>. <source>N Engl J Med</source>
<volume>327</volume>:<fpage>380</fpage>&#x02013;<lpage>384</lpage>, <year>1992</year>.<pub-id pub-id-type="pmid">1294076</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yunginger</surname><given-names>JW</given-names></name><name><surname>Sweeney</surname><given-names>KG</given-names></name><name><surname>Sturner</surname><given-names>WQ</given-names></name><etal/></person-group>
<article-title>Fatal food-induced anaphylaxis</article-title>. <source>JAMA</source>
<volume>260</volume>:<fpage>1450</fpage>&#x02013;<lpage>1452</lpage>, <year>1988</year>.<pub-id pub-id-type="pmid">3404604</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bock</surname><given-names>SA</given-names></name><name><surname>Atkins</surname><given-names>FM</given-names></name></person-group>
<article-title>The natural history of peanut allergy</article-title>. <source>J Allergy Clin Immunol</source>
<volume>83</volume>:<fpage>900</fpage>&#x02013;<lpage>904</lpage>, <year>1989</year>.<pub-id pub-id-type="pmid">2715549</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sicherer</surname><given-names>SH</given-names></name><name><surname>Sampson</surname><given-names>HA</given-names></name></person-group>
<article-title>Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: A 5-year follow-up study</article-title>. <source>J Allergy Clin Immunol</source>
<volume>112</volume>:<fpage>1203</fpage>&#x02013;<lpage>1207</lpage>, <year>2003</year>.<pub-id pub-id-type="pmid">14657884</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sicherer</surname><given-names>SH</given-names></name><name><surname>Mu&#x000f1;oz-Furlong</surname><given-names>A</given-names></name><name><surname>Godbold</surname><given-names>JH</given-names></name><name><surname>Sampson</surname><given-names>HA</given-names></name></person-group>
<article-title>US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-Year follow-up</article-title>. <source>J Allergy Clin Immunol</source>
<volume>125</volume>:<fpage>1322</fpage>&#x02013;<lpage>1326</lpage>, <year>2010</year>.<pub-id pub-id-type="pmid">20462634</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Warner</surname><given-names>JO</given-names></name></person-group>
<article-title>Peanut allergy: A major public health issue</article-title>. <source>Pediatric Allergy and Immunology</source>
<volume>10</volume>:<fpage>14</fpage>&#x02013;<lpage>20</lpage>, <year>1999</year>.<pub-id pub-id-type="pmid">10410912</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kartha</surname><given-names>KK</given-names></name><name><surname>Pahl</surname><given-names>K</given-names></name><name><surname>Leung</surname><given-names>NL</given-names></name><name><surname>Mroginski</surname><given-names>LA</given-names></name></person-group>
<article-title>Plant regeneration from meristems of grain legumes: Soybean, cowpea, peanut, chickpea, and bean</article-title>. <source>Can J Bot</source>
<volume>59</volume>:<fpage>1671</fpage>&#x02013;<lpage>1679</lpage>, <year>1981</year>.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>de Leon</surname><given-names>MP</given-names></name><name><surname>Drew</surname><given-names>AC</given-names></name><name><surname>Glaspole</surname><given-names>IN</given-names></name><etal/></person-group>
<article-title>IgE cross-reactivity between the major peanut allergen Ara h 2 and tree nut allergens</article-title>. <source>Mol Immunol</source>
<volume>44</volume>:<fpage>463</fpage>&#x02013;<lpage>471</lpage>, <year>2007</year>.<pub-id pub-id-type="pmid">16580071</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barre</surname><given-names>A</given-names></name><name><surname>Sordet</surname><given-names>C</given-names></name><name><surname>Culerrier</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Vicilin allergens of peanut and tree nuts (walnut, hazelnut and cashew nut) share structurally related IgE-binding epitopes</article-title>. <source>Mol Immunol</source>
<volume>45</volume>:<fpage>1231</fpage>&#x02013;<lpage>1240</lpage>, <year>2008</year>.<pub-id pub-id-type="pmid">18029017</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sampson</surname><given-names>HA</given-names></name><name><surname>Mu&#x000f1;oz-Furlong</surname><given-names>A</given-names></name><name><surname>Campbell</surname><given-names>RL</given-names></name><etal/></person-group>
<article-title>Second symposium on the definition and management of anaphylaxis: Summary report&#x02014;Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis network symposium</article-title>. <source>J Allergy Clin Immunol</source>
<volume>117</volume>:<fpage>391</fpage>&#x02013;<lpage>397</lpage>, <year>2006</year>.<pub-id pub-id-type="pmid">16461139</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burks</surname><given-names>KD</given-names></name><name><surname>Bock</surname><given-names>SA</given-names></name><name><surname>Atkins</surname><given-names>FM</given-names></name><name><surname>Fleisher</surname><given-names>DM</given-names></name></person-group>
<article-title>Natural history of peanut and tree nut allergy: Development of tree nut allergy/sensitization</article-title>. <comment>Abstract 907</comment>
<source>J Allergy Clin Immunol</source>
<volume>121</volume>:<fpage>S235</fpage>, <year>2008</year>.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burks</surname><given-names>W</given-names></name><name><surname>Sampson</surname><given-names>HA</given-names></name><name><surname>Bannon</surname><given-names>GA</given-names></name></person-group>
<article-title>Peanut allergens</article-title>. <source>Allergy</source>
<volume>53</volume>:<fpage>725</fpage>&#x02013;<lpage>730</lpage>, <year>1998</year>.<pub-id pub-id-type="pmid">9722220</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Radauer</surname><given-names>C</given-names></name><name><surname>Bublin</surname><given-names>M</given-names></name><name><surname>Wagner</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Allergens are distributed into few protein families and possess a restricted number of biochemical functions</article-title>. <source>J Allergy Clin Immunol</source>
<volume>121</volume>:<fpage>847</fpage>&#x02013;<lpage>852.e7</lpage>, <year>2008</year>.<pub-id pub-id-type="pmid">18395549</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kleber-Janke</surname><given-names>T</given-names></name><name><surname>Crameri</surname><given-names>R</given-names></name><name><surname>Appenzeller</surname><given-names>U</given-names></name><etal/></person-group>
<article-title>Selective cloning of peanut allergens, including profilin and 2S albumins, by phage display technology</article-title>. <source>Int Arch Allergy Immunol</source>
<volume>119</volume>:<fpage>265</fpage>&#x02013;<lpage>274</lpage>, <year>1999</year>.<pub-id pub-id-type="pmid">10474031</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roux</surname><given-names>KH</given-names></name><name><surname>Teuber</surname><given-names>SS</given-names></name><name><surname>Sathe</surname><given-names>SK</given-names></name></person-group>
<article-title>Tree nut allergens</article-title>. <source>Int Arch Allergy Immunol</source>
<volume>131</volume>:<fpage>234</fpage>&#x02013;<lpage>244</lpage>, <year>2003</year>.<pub-id pub-id-type="pmid">12915766</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bernard</surname><given-names>H</given-names></name><name><surname>Paty</surname><given-names>E</given-names></name><name><surname>Mondoulet</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Serological characteristics of peanut allergy in children</article-title>. <source>Allergy</source>
<volume>58</volume>:<fpage>1285</fpage>&#x02013;<lpage>1292</lpage>, <year>2003</year>.<pub-id pub-id-type="pmid">14616104</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Astier</surname><given-names>C</given-names></name><name><surname>Morisset</surname><given-names>M</given-names></name><name><surname>Roitel</surname><given-names>O</given-names></name><etal/></person-group>
<article-title>Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy</article-title>. <source>J Allergy Clin Immunol</source>
<volume>118</volume>:<fpage>250</fpage>&#x02013;<lpage>256</lpage>, <year>2006</year>.<pub-id pub-id-type="pmid">16815163</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Flinterman</surname><given-names>AE</given-names></name><name><surname>van Hoffen</surname><given-names>E</given-names></name><name><surname>den Hartog Jager</surname><given-names>CF</given-names></name><etal/></person-group>
<article-title>Children with peanut allergy recognize predominantly Ara h2 and Ara h6, which remains stable over time</article-title>. <source>Clin Exp Allergy</source>
<volume>37</volume>:<fpage>1221</fpage>&#x02013;<lpage>1228</lpage>, <year>2007</year>.<pub-id pub-id-type="pmid">17651153</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koppelman</surname><given-names>SJ</given-names></name><name><surname>Wensing</surname><given-names>M</given-names></name><name><surname>Ertmann</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Relevance of Ara h1, Ara h2 and Ara h3 in peanut-allergic patients, as determined by immunoglobulin E Western blotting, basophil-histamine release and intracutaneous testing: Ara h2 is the most important peanut allergen</article-title>. <source>Clin Exp Allergy</source>
<volume>34</volume>:<fpage>583</fpage>&#x02013;<lpage>590</lpage>, <year>2004</year>.<pub-id pub-id-type="pmid">15080811</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>de Leon</surname><given-names>MP</given-names></name><name><surname>Glaspole</surname><given-names>IN</given-names></name><name><surname>eDrew</surname><given-names>AC</given-names></name><etal/></person-group>
<article-title>Immunological analysis of allergenic cross-reactivity between peanut and tree nuts</article-title>. <source>Clin Exp Allergy</source>
<volume>33</volume>:<fpage>1273</fpage>&#x02013;<lpage>1280</lpage>, <year>2003</year>.<pub-id pub-id-type="pmid">12956750</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maleki</surname><given-names>SJ</given-names></name><name><surname>Teuber</surname><given-names>SS</given-names></name><name><surname>Cheng</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Computationally predicted IgE epitopes of walnut allergens contribute to cross-reactivity with peanuts</article-title>. <source>Allergy</source>
<volume>66</volume>:<fpage>1522</fpage>&#x02013;<lpage>1529</lpage>, <year>2011</year>.<pub-id pub-id-type="pmid">21883278</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Poltronieri</surname><given-names>P</given-names></name><name><surname>Cappello</surname><given-names>MS</given-names></name><name><surname>Dohmae</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Identification and characterization of the IgE-binding proteins 2S albumin and conglutin gamma in almond (<italic>Prunus dulcis</italic>) seeds</article-title>. <source>Int Arch Allergy Immunol</source>
<volume>128</volume>:<fpage>97</fpage>&#x02013;<lpage>104</lpage>, <year>2002</year>.<pub-id pub-id-type="pmid">12065909</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sampson</surname><given-names>HA</given-names></name></person-group>
<article-title>Food allergy</article-title>. <source>J Allergy Clin Immunol</source>
<volume>111</volume>:<fpage>S540</fpage>&#x02013;<lpage>S547</lpage>, <year>2003</year>.<pub-id pub-id-type="pmid">12592300</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bock</surname><given-names>SA</given-names></name><name><surname>Sampson</surname><given-names>HA</given-names></name><name><surname>Atkins</surname><given-names>FM</given-names></name><etal/></person-group>
<article-title>Double-blind, placebo-controlled food challenge (DBPCFC) as an official procedure: A manual</article-title>. <source>J Allergy Clin Immunol</source>
<volume>82</volume>:<fpage>986</fpage>&#x02013;<lpage>997</lpage>, <year>1988</year>.<pub-id pub-id-type="pmid">3060514</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Niggemann</surname><given-names>B</given-names></name><name><surname>Beyer</surname><given-names>KJ</given-names></name></person-group>
<article-title>Diagnosis of food allergy in children: Toward a standardization of food challenge</article-title>. <source>Pediatr Gastroenterol Nutr</source>
<volume>45</volume>:<fpage>399</fpage>&#x02013;<lpage>404</lpage>, <year>2007</year>.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sicherer</surname><given-names>SH</given-names></name><name><surname>Sampson</surname><given-names>HA</given-names></name></person-group>
<article-title>Peanut and tree nut allergy</article-title>. <source>Curr Opin Pediatr</source>
<volume>12</volume>:<fpage>567</fpage>&#x02013;<lpage>573</lpage>, <year>2000</year>.<pub-id pub-id-type="pmid">11106277</pub-id></mixed-citation></ref></ref-list></back></article>